AEON Biopharma, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

AEON

organization

SIC: 2834

SEC Insider

$98.9M

93 transactions

Summary

AEON Biopharma, Inc. (AEON) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $85KSales: $73.8M15 insiders

Date	Insider	Type	Value
2025-05-21	FISCHER JOST	Buy	$29K
2026-06-17	Carter Eric G	A	$0
2026-06-17	FISCHER JOST	A	$0
2026-06-17	Forth Marc	A	$0
2026-06-17	PALMISANO ROBERT J	A	$0
2026-06-17	Thunen Shelley B	A	$0
2026-04-02	Bencich John(CHIEF FINANCIAL OFFICER)	A	$0
2026-03-04	Sy Jennifer(PRINCIPAL ACCOUNTING OFFICER)	A	$0
2026-03-04	Wilson Alexander Blair(CLO, CSO, and Corp Secretary)	A	$0
2026-03-04	Oh Chad(CHIEF MEDICAL OFFICER)	A	$0
2026-02-17	Bancroft Robert E.(PRESIDENT & CEO)	A	$0
2026-02-17	Sy Jennifer(PRINCIPAL ACCOUNTING OFFICER)	A	$0
2026-02-17	Wilson Alexander Blair(CLO, CSO, and Corp Secretary)	A	$0
2026-02-17	Oh Chad(CHIEF MEDICAL OFFICER)	A	$0
2025-05-21	FISCHER JOST	A	$0
2025-05-21	Carter Eric G	A	$0
2025-05-21	PALMISANO ROBERT J	A	$0
2025-05-21	Forth Marc	A	$0
2025-05-21	Sy Jennifer(Chief Accounting Officer)	A	$0
2025-05-21	Oh Chad(Chief Medical Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

AEON Biopharma, Inc. — Contributions, Lobbying & Contracts | Poliscope